Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Press Release Dated September 9, 2019: Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2019
- 99.2 Corporate Presentation
- 99.3 Press Release Dated September 9, 2019: Aptorum Group Has Initiated Ind-enabling Studies for Its ALS-4 Small Molecule Candidate for the Treatment of Infections Caused by Staphylococcus Aureus Including Mrsa
- 99.4 Press Release Dated September 9, 2019: Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
APM similar filings
- 15 Nov 19 Aptorum Group Limited Announces Results of 2019 Annual General Meeting
- 25 Oct 19 Report of Foreign Private Issuer
- 26 Sep 19 Report of Foreign Private Issuer
- 9 Sep 19 Current report (foreign)
- 14 Aug 19 Current report (foreign)
- 8 Jul 19 Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN
- 31 May 19 Report of Foreign Private Issuer
Filing view
External links
Exhibit 99.2